• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挪威霍达兰郡多发性硬化症发病率的50年随访研究。

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.

作者信息

Grytten N, Glad S B, Aarseth J H, Nyland H, Midgard R, Myhr K-M

机构信息

National Multiple Sclerosis Competence Centre, Haukeland University Hospital, Bergen, Norway.

出版信息

Neurology. 2006 Jan 24;66(2):182-6. doi: 10.1212/01.wnl.0000195549.95448.b9.

DOI:10.1212/01.wnl.0000195549.95448.b9
PMID:16434650
Abstract

OBJECTIVE

To assess longitudinal follow-up of the incidence of multiple sclerosis (MS) through five decades and estimate the prevalence rate in Hordaland County, Norway, on January 1, 2003.

METHODS

All patients with MS diagnosed from 1953 to 2003 were identified in the patient records of the Department of Neurology, Haukeland University Hospital, Bergen, Norway. The diagnostic criteria of Poser et al. were applied and only patients with definite and probable MS were included. The study comprises 912 patients, and 666 patients with MS were living in Hordaland on January 1, 2003. The annual incidence rates for the years 1953 to 2003 were calculated.

RESULTS

The total crude prevalence rate on January 1, 2003, was 150.8 per 100,000 population: 191.3 per 100,000 among women and 109.8 per 100,000 among men. The annual incidence of MS increased from 1.8 per 100,000 in 1953 to 1957 to 6.0 per 100,000 in 1993 to 1997.

CONCLUSIONS

Hordaland County, Norway, has changed from a low-risk to a high-risk area for multiple sclerosis (MS) during the last 50 years. During the last 25 years, the incidence of MS has been stable rather than increasing. Systematic longitudinal follow-up studies are essential to calculate reliable prevalence and incidence rates in MS. The results suggest that both methodologic and environmental factors are essential in determining the distribution of MS.

摘要

目的

评估五十年来多发性硬化症(MS)发病率的纵向随访情况,并估算2003年1月1日挪威霍达兰郡的患病率。

方法

在挪威卑尔根市豪克兰大学医院神经科的患者记录中,识别出所有在1953年至2003年期间被诊断为MS的患者。采用波泽等人的诊断标准,仅纳入确诊和可能患有MS的患者。该研究包括912名患者,2003年1月1日有666名MS患者居住在霍达兰郡。计算了1953年至2003年的年发病率。

结果

2003年1月1日的总粗患病率为每10万人150.8例:女性为每10万人191.3例,男性为每10万人109.8例。MS的年发病率从1953年至1957年的每10万人1.8例增至1993年至1997年的每10万人6.0例。

结论

在过去50年中,挪威霍达兰郡已从多发性硬化症(MS)的低风险地区转变为高风险地区。在过去25年中,MS的发病率一直稳定而非上升。系统性的纵向随访研究对于计算MS可靠的患病率和发病率至关重要。结果表明,方法学和环境因素在决定MS的分布方面都至关重要。

相似文献

1
A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.挪威霍达兰郡多发性硬化症发病率的50年随访研究。
Neurology. 2006 Jan 24;66(2):182-6. doi: 10.1212/01.wnl.0000195549.95448.b9.
2
Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study.挪威北特伦德拉格郡的多发性硬化症:一项患病率和发病率研究。
Acta Neurol Scand. 2004 Jun;109(6):378-84. doi: 10.1111/j.1600-0404.2004.00244.x.
3
Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan.萨斯喀彻温省萨斯卡通市多发性硬化症的发病率和患病率
Neurology. 2007 Sep 18;69(12):1224-9. doi: 10.1212/01.wnl.0000276991.13764.77.
4
Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey.希腊西部多发性硬化症的患病率和发病率:一项为期23年的调查。
Neuroepidemiology. 2008;30(3):167-73. doi: 10.1159/000122334. Epub 2008 Apr 2.
5
Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway.奥普兰郡多发性硬化症的患病率和发病率:挪威东部一个内陆郡的横断面基于人群的研究。
Acta Neurol Scand. 2011 Oct;124(4):250-7. doi: 10.1111/j.1600-0404.2010.01465.x. Epub 2010 Dec 10.
6
Possible increasing risk of multiple sclerosis in Catania, Sicily.西西里岛卡塔尼亚地区多发性硬化症风险可能增加。
Neurology. 2005 Oct 25;65(8):1259-63. doi: 10.1212/01.wnl.0000180628.38786.85.
7
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.挪威西部霍达兰郡多发性硬化症发病率和患病率的60年随访研究。
J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):100-5. doi: 10.1136/jnnp-2014-309906. Epub 2015 Feb 24.
8
Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland.爱尔兰东北部多发性硬化症患病率上升的因素。
Mult Scler. 2008 Aug;14(7):880-6. doi: 10.1177/1352458508090663. Epub 2008 Jun 23.
9
Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia.克罗地亚和斯洛文尼亚多发性硬化症持续高发地区。
J Neurol Sci. 2006 Sep 25;247(2):169-72. doi: 10.1016/j.jns.2006.04.002. Epub 2006 Jun 27.
10
[Occurrence of multiple sclerosis in Nordland, 1970-1999].[1970 - 1999年诺德兰郡多发性硬化症的发病情况]
Tidsskr Nor Laegeforen. 2005 Feb 17;125(4):431-3.

引用本文的文献

1
Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study.多发性硬化症发病年龄从 1920 年到 2022 年的增长:一项基于人群的研究。
J Neurol. 2024 Apr;271(4):1610-1617. doi: 10.1007/s00415-023-12047-9. Epub 2023 Dec 14.
2
Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction.多发性硬化症和实验性自身免疫性脑脊髓炎中的性别、衰老与免疫:一种有趣的相互作用。
Front Neurol. 2023 Jan 9;13:1104552. doi: 10.3389/fneur.2022.1104552. eCollection 2022.
3
Nuclear hormone receptors in demyelinating diseases.
脱髓鞘疾病中的核激素受体。
J Neuroendocrinol. 2022 Jul;34(7):e13171. doi: 10.1111/jne.13171. Epub 2022 Jun 22.
4
Apparent changes in the epidemiology and severity of multiple sclerosis.多发性硬化症的流行病学和严重程度的明显变化。
Nat Rev Neurol. 2021 Nov;17(11):676-688. doi: 10.1038/s41582-021-00556-y. Epub 2021 Sep 28.
5
Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan.女性自身免疫性疾病:内分泌转变与一生的风险
Front Endocrinol (Lausanne). 2019 Apr 29;10:265. doi: 10.3389/fendo.2019.00265. eCollection 2019.
6
The economic impact of multiple sclerosis to the patients and their families in Norway.挪威多发性硬化症患者及其家庭的经济负担。
Eur J Health Econ. 2018 Dec;19(9):1243-1257. doi: 10.1007/s10198-018-0971-5. Epub 2018 Apr 21.
7
1,25-Dihydroxyvitamin D suppressed experimental autoimmune encephalomyelitis through both immunomodulation and oligodendrocyte maturation.1,25-二羟基维生素D通过免疫调节和少突胶质细胞成熟来抑制实验性自身免疫性脑脊髓炎。
Exp Mol Pathol. 2017 Jun;102(3):515-521. doi: 10.1016/j.yexmp.2017.05.015. Epub 2017 May 25.
8
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.八十年来挪威多发性硬化症发病率和患病率的时间趋势。
Acta Neurol Scand. 2015;132(199):29-36. doi: 10.1111/ane.12428.
9
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.挪威西部霍达兰郡多发性硬化症发病率和患病率的60年随访研究。
J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):100-5. doi: 10.1136/jnnp-2014-309906. Epub 2015 Feb 24.
10
Multiple sclerosis in the far north--incidence and prevalence in Nordland County, Norway, 1970-2010.挪威最北部的多发性硬化症——1970 - 2010年挪威诺尔兰郡的发病率和患病率
BMC Neurol. 2014 Dec 4;14:226. doi: 10.1186/s12883-014-0226-8.